In order to improve the quality of life of patients with the Ataxia disease, the biotechnological and pharmaceutical industry ...

A significant minority of patients with brain metastases may avoid radiotherapy, but they need to be carefully selected.

The FDA approved IntraBio Inc.'s Aqneursa (levacetylleucine) yesterday for the treatment of ultra rare neurodegenerative ...

Bill Nye, who has helped make science a part of pop culture for a generation of adults and children, is now using his ...

While it was just last week that Zevra Therapeutics’ Miplyffa became the first FDA-approved treatment for the lysosomal ...

European Commission approves OMP Designation for NLX-112 (befiradol) following compelling results in studies funded by the US Dept of De ...

Compared to other solutions, millimeter-wave (mmWave) radar-based gait identification has the merits of being passive, non-invasive, and privacy-preserving, positioning it as the most promising ...

Troriluzole 200 mg dosed orally, once daily, in patients with SCA met the study's primary endpoint on the change from baseline in the modified functional Scale for the Assessment and Rating of ...

Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), today announced positive topline results from pivotal Study BHV4157-206-RWE (NCT06529146) demonstrating the efficacy of troriluzole on the mean ...

Specific gait events are affected by the four primary neuromuscular impairments of spastic ... Three types of CP, spastic, dyskinetic, and ataxic, arise from different regional brain injury. Spastic ...

A slightly faster but less FA-specific scoring method is the Scale for the Assessment and Rating of Ataxia (SARA). This can be used to assess stance, gait, limb kinetic function, sitting, and speech.

The girl gradually showed cognitive regression, reduced language expression, childish behavior, ataxia, and an unsteady gait. When she was 5 years and 8 months old, she was referred to our hospital, ...